Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 1
Submit an article Journal homepage
190
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms

Anna B. Halperna Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USACorrespondence[email protected]
View further author information
,
Megan Othusc Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAView further author information
,
Nicholas P. Howardb Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USAView further author information
,
Paul C. Hendriea Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USAView further author information
,
Mary-Elizabeth M. Percivala Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0002-7016-951XView further author information
ORCID Icon,
Bart L. Scottb Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA;d Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USAView further author information
,
Terry B. Gernsheimera Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USAView further author information
,
Nikita V. Baclige Department of Medicine, Residency Program, University of Washington, Seattle, WA, USAView further author information
,
Sarah A. Buckleyb Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA;e Department of Medicine, Residency Program, University of Washington, Seattle, WA, USAView further author information
,
Ryan D. Cassadaya Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0002-3424-2425View further author information
ORCID Icon,
Garrett A. Hartleyf Pfizer Inc, New York, NY, USAView further author information
,
Verna L. Welchf Pfizer Inc, New York, NY, USAView further author information
,
Elihu H. Esteya Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USAView further author information
&
Roland B. Waltera Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA;g Department of Pathology, University of Washington, Seattle, WA, USA;h Department of Epidemiology, University of Washington, Seattle, WA, USAView further author information
 show all
Pages 234-238 | Received 09 Jul 2020, Accepted 31 Aug 2020, Published online: 13 Sep 2020

References

  • Gillis S, Dann EJ, Rund D. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia. Am J Hematol. 1996;51(1):26–31.
  • Girmenia C, Alimena G, Latagliata R, et al. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Haematologica. 1999;13(4):514–819.
  • Allan DS, Buckstein R, Imrie KR. Outpatient supportive care following chemotherapy for acute myeloblastic leukemia. Leuk Lymphoma. 2001;42(3):339–346.
  • Savoie ML, Nevil TJ, Song KW, et al. Shifting to outpatient management of acute myeloid leukemia: a prospective experience. Ann Oncol. 2006;17(5):763–768.
  • Halim TY, Song KW, Barnett MJ, et al. Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Ann Oncol. 2007;18(7):1246–1252.
  • Møller T, Nielsen OJ, Welinder P, et al. Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemia. Eur J Haematol. 2010;84(4):316–322.
  • Eisele L, Günther F, Ebeling P, et al. Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs. Onkologie. 2010;33(12):658–664.
  • Saini L, Minden MD, Schuh AC, et al. Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia. Am J Hematol. 2012;87(3):323–326.
  • Saini L, Rostein C, Atenafu EG, et al. Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli. BMC Infect Dis. 2013;13:284.
  • Stein EM, Bonifacio G, Latremouille-Viau D, et al. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations. J Med Econ. 2018;21(6):556–563.
  • Matza LS, Deger KA, Howell TA, et al. Health state utilities associated with treatment options for acute myeloid leukemia (AML). J Med Econ. 2019;22(6):567–576.
  • Vaughn JE, Othus M, Powell MA, et al. Resource utilization and safety of outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia or myelodysplastic syndrome: a nonrandomized clinical comparative analysis. JAMA Oncol. 2015;1(8):1120–1127.
  • Halpern AB, Howard NP, Othus M, et al. Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm. Leukemia. 2020;34(2):635–639.
  • Halpern AB, Walter RB, Estey EH. Outpatient induction and consolidation care strategies in acute myeloid leukemia. Curr Opin Hematol. 2019;26(2):65–70.
  • Walter RB, Othus M, Borthakur G, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29(33):4417–4423.
  • Walter RB, Taylor LR, Gardner KM, et al. Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia. Clin Adv Hematol Oncol. 2013;11:571–577.
  • Halpern AB, Walter RB. Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs. academic settings. Hematology Am Soc Hematol Educ Program. 2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.